WO2000066711A3 - Streptococcus gordonii strains resistant to fluorodeoxyuridine - Google Patents

Streptococcus gordonii strains resistant to fluorodeoxyuridine Download PDF

Info

Publication number
WO2000066711A3
WO2000066711A3 PCT/US2000/010924 US0010924W WO0066711A3 WO 2000066711 A3 WO2000066711 A3 WO 2000066711A3 US 0010924 W US0010924 W US 0010924W WO 0066711 A3 WO0066711 A3 WO 0066711A3
Authority
WO
WIPO (PCT)
Prior art keywords
fluorodeoxyuridine
bacteria
resistant
present
strains resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/010924
Other languages
French (fr)
Other versions
WO2000066711A2 (en
Inventor
Dennis E Hruby
Christine A Franke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siga Technologies Inc
Original Assignee
Siga Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siga Technologies Inc filed Critical Siga Technologies Inc
Priority to EP00923588A priority Critical patent/EP1173545B1/en
Priority to AU43687/00A priority patent/AU780780B2/en
Priority to CA002370798A priority patent/CA2370798A1/en
Priority to JP2000615736A priority patent/JP2002542816A/en
Priority to DE60031106T priority patent/DE60031106D1/en
Publication of WO2000066711A2 publication Critical patent/WO2000066711A2/en
Publication of WO2000066711A3 publication Critical patent/WO2000066711A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention features gram-positive bacteria resistant to 5-fluorodeoxyuridine (FUdR). Such bacteria will preferably be commensal, and will not be resistant to antibiotics. Bacteria according to the present invention may also be transformed with DNA encoding an antigenic protein. Such transformed bacteria may be used to formulate a vaccine, in order to stimulate an immune response to the antigenic protein in a patient. The present invention further provides a method for isolating gram-positive bacteria resistant to FUdR.
PCT/US2000/010924 1999-04-29 2000-04-25 Streptococcus gordonii strains resistant to fluorodeoxyuridine Ceased WO2000066711A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP00923588A EP1173545B1 (en) 1999-04-29 2000-04-25 Streptococcus gordonii strains resistant to fluorodeoxyuridine
AU43687/00A AU780780B2 (en) 1999-04-29 2000-04-25 Streptococcus gordonii strains resistant to fluorodeoxyuridine
CA002370798A CA2370798A1 (en) 1999-04-29 2000-04-25 Streptococcus gordonii strains resistant to fluorodeoxyuridine
JP2000615736A JP2002542816A (en) 1999-04-29 2000-04-25 Fluorodeoxyuridine resistant Streptococcus gordonii strain
DE60031106T DE60031106D1 (en) 1999-04-29 2000-04-25 FLUORESE OXYURIDINE RESISTANT STREPTOCOCCUS GORDONII STRAINS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/301,456 US6312955B1 (en) 1999-04-29 1999-04-29 Streptococcus gordonii strains resistant to fluorodeoxyuridine
US09/301,456 1999-04-29

Publications (2)

Publication Number Publication Date
WO2000066711A2 WO2000066711A2 (en) 2000-11-09
WO2000066711A3 true WO2000066711A3 (en) 2001-03-15

Family

ID=23163448

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/010924 Ceased WO2000066711A2 (en) 1999-04-29 2000-04-25 Streptococcus gordonii strains resistant to fluorodeoxyuridine

Country Status (8)

Country Link
US (1) US6312955B1 (en)
EP (1) EP1173545B1 (en)
JP (1) JP2002542816A (en)
AT (1) ATE341613T1 (en)
AU (1) AU780780B2 (en)
CA (1) CA2370798A1 (en)
DE (1) DE60031106D1 (en)
WO (1) WO2000066711A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7825227B2 (en) * 2002-05-09 2010-11-02 Prolexys Pharmaceuticals, Inc. Method for purification of a protein complex and identification of its components

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040943A1 (en) * 1995-06-07 1996-12-19 The Rockefeller University Use of gram-positive bacteria to express recombinant proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040943A1 (en) * 1995-06-07 1996-12-19 The Rockefeller University Use of gram-positive bacteria to express recombinant proteins

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BEAN B. ET AL.: "5-Fluoropyrimidine-Resistant Mutants of Pneumococcus", JOURNAL OF BACTERIOLOGY, vol. 113, no. 3, March 1973 (1973-03-01), pages 1348 - 1355, XP000926065 *
DARLAND G. ET AL.: "Isolation of a thymidine kinase negative mutant of Nocardia lactamdurans", FEMS MICROBIOLOGY LETTERS, vol. 65, 1989, pages 229 - 232, XP000926057 *
FRANKE C. A. ET AL.: "Streptococcus gordonii Strains Resistant to Fluorodeoxyuridine Contain Mutations in the Thymidine Kinase Gene and Are Deficient in Thymidine Kinase Activity", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 44, no. 3, March 2000 (2000-03-01), pages 787 - 789, XP002154467 *
HRUBY D. E.: "Vaccinia Virus: A Novel Approach for Molecular Engineering of Peptide Vaccines", SEMINARS IN HEMATOLOGY, vol. 30, no. 4, October 1993 (1993-10-01), pages 35 - 44, XP000926093 *
MANDELBAUM-SHAVIT F. ET AL.: "MECHANISM OF RESISTANCE OF PEDIOCOCCUS CEREVISIAE STRAINS TO 5-FLUORODEOXYURIDINE", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 543, 1978, pages 1 - 9, XP000926054 *
PALU G. ET AL.: "A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates", VIRUS RESEARCH, vol. 25, 1992, pages 133 - 144, XP000926071 *
SUMMERS W.C. ET AL.: "A Method for Selection of Mutations at the tdk Locus in Escherichia coli", JOURNAL OF BACTERIOLOGY, vol. 175, no. 18, September 1993 (1993-09-01), pages 6049 - 6051, XP000926064 *

Also Published As

Publication number Publication date
EP1173545A2 (en) 2002-01-23
WO2000066711A2 (en) 2000-11-09
AU780780B2 (en) 2005-04-14
EP1173545B1 (en) 2006-10-04
AU4368700A (en) 2000-11-17
DE60031106D1 (en) 2006-11-16
US6312955B1 (en) 2001-11-06
CA2370798A1 (en) 2000-11-09
JP2002542816A (en) 2002-12-17
ATE341613T1 (en) 2006-10-15

Similar Documents

Publication Publication Date Title
WO2000039299A3 (en) Streptococcus antigens
HUP0201783A2 (en) Anti-alfavbetha3 recombinant human antibodies, nucleic acids encoding same and methods
MXPA03000103A (en) Streptococcus antigens.
WO2000006738A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
WO2000006737A3 (en) Streptococcus pneumoniae proteins and nucleic acid molecules
PL325373A1 (en) Compounds and methods useful in tuberculosos immunotherapy and diagnostics
WO2001096368A3 (en) Use of coiled-coil structural scaffold to generate structure-specific peptides
EP1300468A3 (en) TRNA synthetase
EP1757697A3 (en) Group B streptococcus antigens
ATE323721T1 (en) CHOLINE-BINDING PROTEIN USED AS AN PNEUMOCOCCAL VACCINE
WO1998016646A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO2000006736A3 (en) Nucleic acids and proteins from group b streptococcus
AU6867801A (en) Fusion proteins of mycobacterium tuberculosis
WO2002079241A3 (en) Secreted streptococcus pneumoniae proteins
WO2002034773A3 (en) Streptococcal genes
WO2001032882A3 (en) Nucleic acids and proteins from group b streptococcus
WO1997044463A3 (en) Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin
WO1999004011A3 (en) Hiv-1 group o antigens and uses thereof
WO2000037646A3 (en) Group b streptococcus proteins, and their use
WO2002057315A3 (en) Streptococcal streptolysin s vaccines
CA2361987A1 (en) Goodpasture antigen binding protein
WO2003093298A3 (en) Immunogenic peptides
DE60031106D1 (en) FLUORESE OXYURIDINE RESISTANT STREPTOCOCCUS GORDONII STRAINS
WO2000039301A3 (en) Methods for using mycobacterium tuberculosis molecules as immunological adjuvants

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref document number: 2370798

Country of ref document: CA

Ref country code: CA

Ref document number: 2370798

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000923588

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 615736

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000923588

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2000923588

Country of ref document: EP